Filing Details
- Accession Number:
- 0001140361-11-001841
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-07 12:54:47
- Reporting Period:
- 2011-01-05
- Filing Date:
- 2011-01-07
- Accepted Time:
- 2011-01-07 12:54:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
707511 | Regenerx Biopharmaceuticals Inc | RGRX.OB | Pharmaceutical Preparations (2834) | 521253406 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1092601 | Spa Finanziaria Tau Sigma | Via Sudafrica, 20 Rome L6 00144 | No | No | Yes | No | |
1168857 | Lda Farmaceutica Defiante | 1 New York Street New York NY 10005 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-01-05 | 925,926 | $0.27 | 12,937,111 | No | 4 | P | Indirect | Indirect |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Indirect |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2011-01-05 | 1 | $0.00 | 370,370 | $0.38 |
Common Stock | Common Stock Warrants (right to buy) | Disposition | 2011-01-05 | 1 | $0.00 | 256,148 | $4.06 |
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2011-01-05 | 1 | $0.00 | 256,148 | $0.38 |
Common Stock | Common Stock Warrants (right to buy) | Disposition | 2011-01-05 | 1 | $0.00 | 333,333 | $2.75 |
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2011-01-05 | 1 | $0.00 | 333,333 | $0.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1 | 2011-07-07 | 2016-01-07 | No | 4 | J | Indirect |
0 | 2011-03-16 | No | 4 | J | Indirect | |
1 | 2011-12-31 | No | 4 | J | Indirect | |
0 | 2011-12-21 | No | 4 | J | Indirect | |
2 | 2011-12-31 | No | 4 | J | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 984,615 | Direct |
Footnotes
- Securities directly owned by Defiante Farmaceutica S.A. ("Defiante"). Defiante is 58% directly owned by Sigma Tau Finanziaria S.p.A. ("Sigma Tau") and 42% directly owned by Sigma Tau's wholly-owned subsidiary, Sigma Tau International S.A.
- The Warrant was issued by the Issuer to Defiante in consideration of Defiante's purchase of Common Stock.
- The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on September 16, 2006.
- The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant became exercisable on December 21, 2006.